Page last updated: 2024-08-17

quinoxalines and guanidine

quinoxalines has been researched along with guanidine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acheampong, AA; Breau, A; Chien, DS; Garst, M; Harcourt, D; Lam, S; Munk, SA; Nguyen, H; Tang-Liu, D; Usansky, J; Vekich, S1
Butini, S; Caccia, S; Cagnotto, A; Campiani, G; Cervo, L; Dalla Valle, F; Fracasso, C; Gemma, S; Goegan, M; Greco, G; Hamon, M; Mennini, T; Morelli, E; Nacci, V; Novellino, E1
Chan, KK; Gao, H; Shen, LL; Snapka, RM; Yamasaki, EF1

Other Studies

3 other study(ies) available for quinoxalines and guanidine

ArticleYear
Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase.
    Xenobiotica; the fate of foreign compounds in biological systems, 1996, Volume: 26, Issue:10

    Topics: Acetates; Adult; Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Brimonidine Tartrate; Chromatography, Liquid; Dogs; Guanidine; Guanidines; Haplorhini; Humans; Liver; Male; Mass Spectrometry; Quinoxalines; Rabbits; Rats; Species Specificity

1996
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Journal of medicinal chemistry, 1999, Oct-21, Volume: 42, Issue:21

    Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Guanidine; Guinea Pigs; Hybrid Cells; In Vitro Techniques; Ligands; Male; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship

1999
Chloroquinoxaline sulfonamide (NSC 339004) is a topoisomerase IIalpha/beta poison.
    Cancer research, 2000, Nov-01, Volume: 60, Issue:21

    Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidine; Isoenzymes; Kidney; Protein Denaturation; Quinoxalines; Sulfanilamides; Topoisomerase II Inhibitors

2000